Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

Healthcare Biotechnology
iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Satellos Bioscience Inc Com > NEWS..
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(13)
•••
Comment by Rubberbandon Apr 25, 2021 3:50pm
193 Views
Post# 33063895

RE:RE:RE:RE:RE:NEWS..

RE:RE:RE:RE:RE:NEWS..Again I am not disagreeing with you about anything they you are saying, but if you are wanting that to happen then  be close to the sell button when this opens. With again this over subscription and Burton also in this I believe we will see a big jump in price once this opens up. Most important thing is what will  the RS numbers be. 1/60,1/40,1/20. None of us know for sure, if they do a 1/60 split then opening price after everything should be at or around $5.10 per share. Time will tell.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities